From: Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis
Adverse events (N = 108)
Serious adverse events (N = 108)
n (%)
Anaemia
2 (1.9)
P. vivax malaria
1 (0.9)
–
Nausea